Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection

Detalhes bibliográficos
Autor(a) principal: Nunes, Cintia Zoya [UNIFESP]
Data de Publicação: 2013
Outros Autores: Marra, Alexandre Rodrigues [UNIFESP], Edmond, Michael B., Victor, Elivane da Silva, Pereira, Carlos Alberto Pires [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
dARK ID: ark:/48912/001300000bv2v
Texto Completo: http://dx.doi.org/10.1186/1471-2334-13-486
http://repositorio.unifesp.br/handle/11600/36879
Resumo: Background: Few studies have assessed the time to blood culture positivity as a predictor of clinical outcome in fungal bloodstream infections (BSIs). the purpose of this study was to evaluate the time to positivity (TTP) of blood cultures in patients with Candida albicans BSIs and to assess its impact on clinical outcome.Methods: A historical cohort study with 89 adults patients with C. albicans BSIs. TTP was defined as the time between the start of incubation and the time that the automated alert signal indicating growth in the culture bottle sounded.Results: Patients with BSIs and TTPs of culture of <= 36 h (n = 39) and >36 h (n = 50) were compared. Septic shock occurred in 46.2% of patients with TTPs of <= 36 h and in 40.0% of patients with TTP of >36 h (p = 0.56). A central venous catheter source was more common with a BSI TTP of <= 36 h (p = 0.04). Univariate analyis revealed that APACHE II score >= 20 at BSI onset, the development of at least one organ system failure (respiratory, cardiovascular, renal, hematologic, or hepatic), SOFA at BSI onset, SAPS II at BSI onset, and time to positivity were associated with death. By using logistic regression analysis, the only independent predictor of death was time to positivity (1.04; 95% CI, 1.0-1.1, p = 0.035), with the chance of the patient with C. albicans BSI dying increasing 4.0% every hour prior to culture positivity.Conclusion: A longer time to positivity was associated with a higher mortality for Candida albicans BSIs; therefore, initiating empiric treatment with antifungals may improve outcomes.
id UFSP_1829882ae156938b7be92fa5773dc0af
oai_identifier_str oai:repositorio.unifesp.br/:11600/36879
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infectionCandidaBloodstream infectionTime to positivityAntifungal therapyBackground: Few studies have assessed the time to blood culture positivity as a predictor of clinical outcome in fungal bloodstream infections (BSIs). the purpose of this study was to evaluate the time to positivity (TTP) of blood cultures in patients with Candida albicans BSIs and to assess its impact on clinical outcome.Methods: A historical cohort study with 89 adults patients with C. albicans BSIs. TTP was defined as the time between the start of incubation and the time that the automated alert signal indicating growth in the culture bottle sounded.Results: Patients with BSIs and TTPs of culture of <= 36 h (n = 39) and >36 h (n = 50) were compared. Septic shock occurred in 46.2% of patients with TTPs of <= 36 h and in 40.0% of patients with TTP of >36 h (p = 0.56). A central venous catheter source was more common with a BSI TTP of <= 36 h (p = 0.04). Univariate analyis revealed that APACHE II score >= 20 at BSI onset, the development of at least one organ system failure (respiratory, cardiovascular, renal, hematologic, or hepatic), SOFA at BSI onset, SAPS II at BSI onset, and time to positivity were associated with death. By using logistic regression analysis, the only independent predictor of death was time to positivity (1.04; 95% CI, 1.0-1.1, p = 0.035), with the chance of the patient with C. albicans BSI dying increasing 4.0% every hour prior to culture positivity.Conclusion: A longer time to positivity was associated with a higher mortality for Candida albicans BSIs; therefore, initiating empiric treatment with antifungals may improve outcomes.Universidade Federal de São Paulo UNIFESP, Div Infect Dis, São Paulo, BrazilHosp Israelita Albert Einstein, Div Med Practice, São Paulo, BrazilVirginia Commonwealth, Univ Sch Med, Dept Internal Med, Richmond, VA USAUniversidade Federal de São Paulo UNIFESP, Div Infect Dis, São Paulo, BrazilWeb of ScienceBiomed Central LtdUniversidade Federal de São Paulo (UNIFESP)Hosp Israelita Albert EinsteinVirginia CommonwealthNunes, Cintia Zoya [UNIFESP]Marra, Alexandre Rodrigues [UNIFESP]Edmond, Michael B.Victor, Elivane da SilvaPereira, Carlos Alberto Pires [UNIFESP]2016-01-24T14:34:35Z2016-01-24T14:34:35Z2013-10-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion7application/pdfhttp://dx.doi.org/10.1186/1471-2334-13-486Bmc Infectious Diseases. London: Biomed Central Ltd, v. 13, 7 p., 2013.10.1186/1471-2334-13-486WOS000328901800001.pdf1471-2334http://repositorio.unifesp.br/handle/11600/36879WOS:000328901800001ark:/48912/001300000bv2vengBmc Infectious Diseasesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-31T16:03:37Zoai:repositorio.unifesp.br/:11600/36879Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-12-11T20:09:54.867361Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection
title Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection
spellingShingle Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection
Nunes, Cintia Zoya [UNIFESP]
Candida
Bloodstream infection
Time to positivity
Antifungal therapy
title_short Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection
title_full Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection
title_fullStr Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection
title_full_unstemmed Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection
title_sort Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection
author Nunes, Cintia Zoya [UNIFESP]
author_facet Nunes, Cintia Zoya [UNIFESP]
Marra, Alexandre Rodrigues [UNIFESP]
Edmond, Michael B.
Victor, Elivane da Silva
Pereira, Carlos Alberto Pires [UNIFESP]
author_role author
author2 Marra, Alexandre Rodrigues [UNIFESP]
Edmond, Michael B.
Victor, Elivane da Silva
Pereira, Carlos Alberto Pires [UNIFESP]
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Hosp Israelita Albert Einstein
Virginia Commonwealth
dc.contributor.author.fl_str_mv Nunes, Cintia Zoya [UNIFESP]
Marra, Alexandre Rodrigues [UNIFESP]
Edmond, Michael B.
Victor, Elivane da Silva
Pereira, Carlos Alberto Pires [UNIFESP]
dc.subject.por.fl_str_mv Candida
Bloodstream infection
Time to positivity
Antifungal therapy
topic Candida
Bloodstream infection
Time to positivity
Antifungal therapy
description Background: Few studies have assessed the time to blood culture positivity as a predictor of clinical outcome in fungal bloodstream infections (BSIs). the purpose of this study was to evaluate the time to positivity (TTP) of blood cultures in patients with Candida albicans BSIs and to assess its impact on clinical outcome.Methods: A historical cohort study with 89 adults patients with C. albicans BSIs. TTP was defined as the time between the start of incubation and the time that the automated alert signal indicating growth in the culture bottle sounded.Results: Patients with BSIs and TTPs of culture of <= 36 h (n = 39) and >36 h (n = 50) were compared. Septic shock occurred in 46.2% of patients with TTPs of <= 36 h and in 40.0% of patients with TTP of >36 h (p = 0.56). A central venous catheter source was more common with a BSI TTP of <= 36 h (p = 0.04). Univariate analyis revealed that APACHE II score >= 20 at BSI onset, the development of at least one organ system failure (respiratory, cardiovascular, renal, hematologic, or hepatic), SOFA at BSI onset, SAPS II at BSI onset, and time to positivity were associated with death. By using logistic regression analysis, the only independent predictor of death was time to positivity (1.04; 95% CI, 1.0-1.1, p = 0.035), with the chance of the patient with C. albicans BSI dying increasing 4.0% every hour prior to culture positivity.Conclusion: A longer time to positivity was associated with a higher mortality for Candida albicans BSIs; therefore, initiating empiric treatment with antifungals may improve outcomes.
publishDate 2013
dc.date.none.fl_str_mv 2013-10-20
2016-01-24T14:34:35Z
2016-01-24T14:34:35Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1186/1471-2334-13-486
Bmc Infectious Diseases. London: Biomed Central Ltd, v. 13, 7 p., 2013.
10.1186/1471-2334-13-486
WOS000328901800001.pdf
1471-2334
http://repositorio.unifesp.br/handle/11600/36879
WOS:000328901800001
dc.identifier.dark.fl_str_mv ark:/48912/001300000bv2v
url http://dx.doi.org/10.1186/1471-2334-13-486
http://repositorio.unifesp.br/handle/11600/36879
identifier_str_mv Bmc Infectious Diseases. London: Biomed Central Ltd, v. 13, 7 p., 2013.
10.1186/1471-2334-13-486
WOS000328901800001.pdf
1471-2334
WOS:000328901800001
ark:/48912/001300000bv2v
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Bmc Infectious Diseases
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 7
application/pdf
dc.publisher.none.fl_str_mv Biomed Central Ltd
publisher.none.fl_str_mv Biomed Central Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1818602440139735040